DRUGREBOOT.AI

What this means for you

Not registered yet, but its 01 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99262228

Mark type

Stylized text

Filed

01 Jul 2025

Attorney of record

MICHAEL LEE EVANS

Goods and services

• Class 042 — Scientific and technological services: International Class 42: Providing medical and scientific research information in the field of clinical trials. Drugreboot.ai is software service that analyzes a failed trial to discover molecular features associated with drug response. Drugreboot.ai combines the molecular features with the patient's clinical attributes to predict the reasons why the drug failed in the clinical trial and provides additional analysis using disease models identifies strategies for salvaging the therapy. The software provides the user with information on clinical trials failures and next steps, the main service here is that of a software services that assists those conducting clinical trials in pivoting to other uses Providing medical and scientific research information in the field of clinical trials.

Owner

• ThinkBio.ai., Inc., Ontario, CA, US

Prosecution history

• 11 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 11 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 06 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 06 Mar 2026 — NON-FINAL ACTION E-MAILED
• 06 Mar 2026 — NON-FINAL ACTION WRITTEN
• 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 11 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
• 10 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 10 Feb 2026 — FINAL REFUSAL E-MAILED
• 10 Feb 2026 — FINAL REFUSAL WRITTEN
• 11 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 11 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED